| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5S rRNA binding | 6.14e-05 | 14 | 113 | 3 | GO:0008097 | |
| GeneOntologyMolecularFunction | rRNA binding | 8.57e-05 | 79 | 113 | 5 | GO:0019843 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 1.80e-05 | 275 | 111 | 9 | GO:0016072 | |
| GeneOntologyBiologicalProcess | rRNA processing | 3.49e-05 | 230 | 111 | 8 | GO:0006364 | |
| GeneOntologyBiologicalProcess | DNA damage response | CDK9 PMS2P5 SP100 ERCC5 NOP53 NSMCE3 FANCM ZNF365 NEDD4 PYHIN1 KAT2B AUNIP KMT5B PRKDC TOP2A KIF22 | 5.42e-05 | 959 | 111 | 16 | GO:0006974 |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 8.54e-05 | 336 | 111 | 9 | GO:0042254 | |
| GeneOntologyCellularComponent | nuclear body | CDK9 SP100 CDK12 NELFA CARMIL1 U2AF2 SFMBT2 PYHIN1 UBE2O CCNB3 SETBP1 BRD1 USPL1 SON KIF22 | 7.71e-05 | 903 | 110 | 15 | GO:0016604 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 2.16e-04 | 56 | 110 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | nuclear speck | 4.58e-04 | 431 | 110 | 9 | GO:0016607 | |
| Domain | RuvA_2-like | 1.67e-05 | 9 | 111 | 3 | IPR010994 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOA RIOK1 UBAP2 DSC1 CDK12 CARMIL1 MATR3 RPS27 NCAPH ZNF512B CSDE1 CRACD UBE2O XRN1 PLCG1 PRKDC NMT1 RPL3 RPL4 TOP2A TP53BP2 SON | 4.57e-13 | 934 | 115 | 22 | 33916271 |
| Pubmed | CDK9 ELOA RPL36 DDX31 RRP1B NOP53 U2AF2 DDX56 RPS27 NSMCE3 PRKDC PLEC RPL3 RPL4 TOP2A RBM34 | 7.48e-13 | 419 | 115 | 16 | 15635413 | |
| Pubmed | CDK9 ELOA RPL36 DDX31 RRP1B CDK12 RNPC3 MATR3 U2AF2 DDX56 RPS27 SRBD1 CSDE1 NKTR RPL3 RPL4 TOP2A RBM34 SON | 2.56e-12 | 713 | 115 | 19 | 29802200 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL36 RIOK1 DSC1 RRP1B NOP53 NOL12 MATR3 U2AF2 DDX56 RPS27 JPH1 CSDE1 PRKDC GFPT2 PLEC RPL3 HSPA2 RPL4 TOP2A SON KIF22 | 5.37e-12 | 949 | 115 | 21 | 36574265 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ELOA DDX31 RRP1B CDK12 NOP53 RNPC3 MATR3 DDX56 RPS27 SRBD1 CSDE1 XRN1 PRKDC RPL4 TOP2A RBM34 SON KIF22 | 6.81e-11 | 759 | 115 | 18 | 35915203 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CDK9 ELOA RPL36 DDX31 DSC1 RRP1B NOP53 MATR3 U2AF2 DDX56 RPS27 SRBD1 PDZD8 PRKDC PLEC RPL3 RPL4 TOP2A SON KIF22 | 8.99e-11 | 989 | 115 | 20 | 36424410 |
| Pubmed | RPL36 DSC1 RRP1B CDK12 NOP53 MATR3 U2AF2 DDX56 RPS27 NSMCE3 CRACD NMT1 RPL3 RPL4 TOP2A RBM34 SON | 3.26e-10 | 731 | 115 | 17 | 29298432 | |
| Pubmed | CDK9 RPL36 UBAP2 DDX31 RRP1B NOP53 NOL12 MATR3 U2AF2 DDX56 RPS27 ZNF512B PRKDC RPL3 RPL4 TOP2A RBM34 SON | 3.95e-10 | 847 | 115 | 18 | 35850772 | |
| Pubmed | DDX31 RRP1B NOP53 U2AF2 DDX56 CSDE1 UBE2O SYNE2 XRN1 PRKDC PLEC RPL3 HSPA2 RPL4 RBM34 SON | 5.34e-10 | 653 | 115 | 16 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CDK9 ELOA SP100 RPL36 DSC1 RRP1B NOP53 MATR3 U2AF2 DDX56 RPS27 SRBD1 NCAPH CSDE1 PRKDC PLEC NMT1 RPL3 RPL4 TOP2A RBM34 | 9.19e-10 | 1257 | 115 | 21 | 36526897 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ELOA RPL36 DSC1 RRP1B MATR3 U2AF2 DDX56 RPS27 ZNF512B PRKDC BRD1 RPL3 RPL4 TOP2A RBM34 | 1.65e-09 | 605 | 115 | 15 | 28977666 |
| Pubmed | CDK9 RPL36 UBAP2 RRP1B NELFA MATR3 U2AF2 RPS27 SRBD1 PRKDC RPL3 RPL4 TOP2A RBM34 TP53BP2 | 2.05e-09 | 615 | 115 | 15 | 31048545 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK9 UBAP2 MATK CARMIL1 MATR3 MAGI3 RPS27 STK32C DNAH7 NEDD4 SYNE2 XRN1 SSH2 PLEC BRD1 PLK4 TP53BP2 | 3.81e-09 | 861 | 115 | 17 | 36931259 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | ELOA RIOK1 RRP1B NOP53 MATR3 U2AF2 DDX56 SRBD1 RPL3 RPL4 RBM34 | 9.00e-09 | 316 | 115 | 11 | 31665637 |
| Pubmed | ELOA SP100 RPL36 ERCC5 MATR3 U2AF2 MAGI3 SRBD1 NCAPH SFMBT2 ZNF608 SYNE2 STRN4 XRN1 PRKDC PLEC USPL1 RPL3 HSPA2 RPL4 TOP2A | 1.03e-08 | 1442 | 115 | 21 | 35575683 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DDX31 RRP1B NOP53 NOL12 MATR3 U2AF2 RPS27 CSDE1 UBE2O XRN1 PRKDC RPL3 RPL4 TOP2A RBM34 SON | 1.08e-08 | 807 | 115 | 16 | 22681889 |
| Pubmed | 3.35e-08 | 208 | 115 | 9 | 11790298 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CDK9 RPL36 RIOK1 ERCC5 RRP1B CARMIL1 MATR3 U2AF2 RPS27 NCAPH CSDE1 UBE2O SYNE2 PRKDC PLEC NMT1 RPL3 RPL4 TOP2A SON | 3.95e-08 | 1415 | 115 | 20 | 28515276 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ELOA ERCC5 CDK12 NELFA MATK PDPK1 CARMIL1 MATR3 NSMCE3 ZNF644 PRKDC PLEC NMT1 TOP2A SON | 4.34e-08 | 774 | 115 | 15 | 15302935 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | RPL36 RIOK1 RRP1B CDK12 MATR3 U2AF2 DDX56 RPS27 SRBD1 RPL3 HSPA2 RPL4 RBM34 SON | 5.84e-08 | 678 | 115 | 14 | 30209976 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RIOK1 DDX31 RRP1B MATR3 U2AF2 DDX56 RPS27 NCAPH CSDE1 NKTR PRKDC PLEC RPL3 RPL4 TOP2A RBM34 UQCRFS1P1 SON KIF22 | 6.64e-08 | 1318 | 115 | 19 | 30463901 |
| Pubmed | ELOA RPL36 DDX31 RRP1B NOP53 NOL12 DDX56 PRKDC RPL3 RPL4 TOP2A RBM34 | 7.61e-08 | 483 | 115 | 12 | 36912080 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPL36 OSTM1 RRP1B NOP53 MATR3 U2AF2 DDX56 JPH1 ZNF512B NBAS ZNF644 SYNE2 STRN4 PDZD8 RPL3 RPL4 TOP2A RBM34 USP33 SON | 9.74e-08 | 1496 | 115 | 20 | 32877691 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CDK9 ELOA RPL36 RRP1B CDK12 RNPC3 NOL12 MATR3 U2AF2 SPOCK2 DDX56 DCX ZNF512B PRKDC PLEC RPL4 SON | 1.05e-07 | 1082 | 115 | 17 | 38697112 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ELOA UBAP2 RRP1B CDK12 NOP53 MATR3 U2AF2 RPS27 NSMCE3 FANCM ZNF512B ZNF644 PRKDC HSPA2 TOP2A SON | 1.08e-07 | 954 | 115 | 16 | 36373674 |
| Pubmed | 1.36e-07 | 245 | 115 | 9 | 21182205 | ||
| Pubmed | RIOK1 IQCH RRP1B MATR3 RPS27 JPH1 SETBP1 XRN1 PRKDC USPL1 RPL3 HSPA2 | 1.46e-07 | 513 | 115 | 12 | 25798074 | |
| Pubmed | ELOA RPL36 CDK12 NELFA NOL12 DDX56 SRBD1 RPL3 RPL4 TOP2A RBM34 | 1.50e-07 | 417 | 115 | 11 | 36537216 | |
| Pubmed | CDK9 SP100 TCP11L1 ZNF212 NOL12 U2AF2 DDX56 JPH1 ZNF512B KAT2B ZNF608 KMT5B CCNB3 XRN1 BRD1 TOP2A SON | 1.63e-07 | 1116 | 115 | 17 | 31753913 | |
| Pubmed | 1.73e-07 | 333 | 115 | 10 | 36779763 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.77e-07 | 182 | 115 | 8 | 32239614 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.97e-07 | 256 | 115 | 9 | 33397691 | |
| Pubmed | UBAP2 RRP1B CDK12 ZNF212 MATR3 PLXND1 NCAPH ZNF512B KMT2C UBE2O ZNF608 SETBP1 | 2.02e-07 | 529 | 115 | 12 | 14621295 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL36 RRP1B MTF2 MATR3 U2AF2 DDX56 SRBD1 FANCM ZNF512B KMT2C ZNF644 NKTR PRKDC RPL3 RPL4 TOP2A SON KIF22 | 2.59e-07 | 1294 | 115 | 18 | 30804502 |
| Pubmed | CDK9 RRP1B MATR3 U2AF2 CSDE1 PRKDC RPL3 HSPA2 RPL4 TOP2A KIF22 | 2.63e-07 | 441 | 115 | 11 | 31239290 | |
| Pubmed | UBAP2 CDK12 MATR3 NCAPH CSDE1 KMT2C UBE2O STRN4 XRN1 PRKDC TOP2A TP53BP2 | 3.00e-07 | 549 | 115 | 12 | 38280479 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 3.64e-07 | 361 | 115 | 10 | 30344098 | |
| Pubmed | RRP1B MATR3 U2AF2 DDX56 SRBD1 CSDE1 XRN1 RPL3 RPL4 TOP2A SON | 4.82e-07 | 469 | 115 | 11 | 37314180 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL36 DSC1 MATR3 U2AF2 DDX56 SRBD1 NCAPH CSDE1 XRN1 PLCG1 PRKDC PLEC RPL3 RPL4 TOP2A RBM34 TP53BP2 SON | 4.95e-07 | 1353 | 115 | 18 | 29467282 |
| Pubmed | 5.26e-07 | 210 | 115 | 8 | 16565220 | ||
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 5.69e-07 | 145 | 115 | 7 | 27049334 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SP100 RPL36 RRP1B MATR3 RPS27 NCAPH NEDD4 CSDE1 PRKDC PLEC RPL3 HSPA2 RPL4 UQCRFS1P1 | 8.51e-07 | 847 | 115 | 14 | 35235311 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA DDX31 RRP1B MTF2 SRBD1 ZNF512B UBE2O ZNF644 BRD1 TOP2A RBM34 KIF22 | 8.79e-07 | 608 | 115 | 12 | 36089195 |
| Pubmed | CDK9 ELOA RIOK1 CDK12 RPS27 PLXND1 NEDD4 RHOQ KAT2B GFPT2 SSH2 RPL3 PLK4 | 9.47e-07 | 730 | 115 | 13 | 34857952 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.23e-06 | 235 | 115 | 8 | 30258100 | |
| Pubmed | 1.34e-06 | 104 | 115 | 6 | 31365120 | ||
| Pubmed | RPL36 DSC1 RRP1B MATR3 U2AF2 RPS27 CSDE1 PRKDC RPL3 RPL4 TOP2A RBM34 | 1.52e-06 | 641 | 115 | 12 | 36057605 | |
| Pubmed | 1.62e-06 | 244 | 115 | 8 | 30349055 | ||
| Pubmed | 1.67e-06 | 245 | 115 | 8 | 35652658 | ||
| Pubmed | RPL36 DSC1 MATR3 NSMCE3 FANCM PRKDC PLEC RPL3 RPL4 TOP2A SON KIF22 | 1.81e-06 | 652 | 115 | 12 | 31180492 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 1.83e-06 | 248 | 115 | 8 | 27926873 | |
| Pubmed | 2.08e-06 | 340 | 115 | 9 | 29478914 | ||
| Pubmed | 2.12e-06 | 253 | 115 | 8 | 29911972 | ||
| Pubmed | RIOK1 UBAP2 RRP1B MATR3 SRBD1 CSDE1 PRKDC PLEC RPL3 RPL4 RBM34 | 2.30e-06 | 551 | 115 | 11 | 34728620 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 2.53e-06 | 259 | 115 | 8 | 30404004 | |
| Pubmed | ELOA RIOK1 UBAP2 DDX31 RRP1B CDK12 MATR3 TRPM2 U2AF2 DDX56 CSDE1 NKTR PLEC NMT1 RBM34 UQCRFS1P1 SON | 2.75e-06 | 1371 | 115 | 17 | 36244648 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPL36 MATR3 U2AF2 RPS27 NBAS TDRD10 PRKDC PLEC NMT1 RPL3 HSPA2 RPL4 UQCRFS1P1 | 2.85e-06 | 807 | 115 | 13 | 30575818 |
| Pubmed | 3.12e-06 | 187 | 115 | 7 | 26460568 | ||
| Pubmed | 3.16e-06 | 267 | 115 | 8 | 33417871 | ||
| Pubmed | CDK9 RPL36 RRP1B PPFIBP2 MATR3 U2AF2 RPS27 RHOQ ZNF608 XRN1 PRKDC RPL3 RPL4 TOP2A TP53BP2 KIF22 | 3.62e-06 | 1247 | 115 | 16 | 27684187 | |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 4.48e-06 | 128 | 115 | 6 | 28027390 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL36 RIOK1 DSC1 RRP1B NOP53 MATR3 U2AF2 DDX56 RPS27 NCAPH UBE2O PLCG1 PRKDC RPL3 RPL4 TOP2A RBM34 | 4.60e-06 | 1425 | 115 | 17 | 30948266 |
| Pubmed | RPL36 UBAP2 DDX31 RRP1B NOP53 MATR3 DDX56 ZNF512B KMT2C KAT2B UBE2O ZNF608 ZNF644 SYNE2 XRN1 GFPT2 RBM34 | 4.77e-06 | 1429 | 115 | 17 | 35140242 | |
| Pubmed | RPL36 RRP1B MATR3 U2AF2 RPS27 PRKDC PLEC NMT1 RPL3 RPL4 TOP2A | 5.26e-06 | 601 | 115 | 11 | 33658012 | |
| Pubmed | 5.55e-06 | 76 | 115 | 5 | 27542412 | ||
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 5.58e-06 | 384 | 115 | 9 | 31059266 | |
| Pubmed | 5.71e-06 | 205 | 115 | 7 | 28927264 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL36 RIOK1 CDK12 TCP11L1 MATR3 U2AF2 RPS27 NCAPH UBE2O PRKDC PLEC NMT1 RPL3 HSPA2 RPL4 | 6.09e-06 | 1149 | 115 | 15 | 35446349 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.43e-06 | 398 | 115 | 9 | 35016035 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RPL36 MATR3 U2AF2 RPS27 CSDE1 RHOQ PRKDC PLEC RPL3 RPL4 TOP2A | 7.72e-06 | 626 | 115 | 11 | 33644029 |
| Pubmed | CDK9 ELOA RPL36 MTF2 NELFA MATR3 CRACD NBAS KMT2C KMT5B XRN1 NKTR PLCG1 SSH2 BRD1 RBM34 | 7.90e-06 | 1327 | 115 | 16 | 32694731 | |
| Pubmed | RPL36 DDX31 RRP1B TRAPPC8 JPH1 ZNF512B NBAS UBE2O ZNF644 SYNE2 PDZD8 RPL3 HSPA2 RPL4 RBM34 FAM177A1 USP33 | 8.04e-06 | 1487 | 115 | 17 | 33957083 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ELOA SP100 RPL36 UBAP2 DSC1 RRP1B CDK12 MATR3 ZNF608 ZNF644 PRKDC PLEC RPL3 RPL4 TOP2A | 1.05e-05 | 1203 | 115 | 15 | 29180619 |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22454520 | ||
| Pubmed | CDK9 RIOK1 CDK12 NOP53 MATR3 U2AF2 DDX56 CSDE1 PLCG1 PRKDC GFPT2 | 1.14e-05 | 653 | 115 | 11 | 33742100 | |
| Pubmed | 1.15e-05 | 42 | 115 | 4 | 34244791 | ||
| Pubmed | RPL36 RRP1B MATR3 U2AF2 RPS27 CSDE1 PRKDC PLEC RPL3 RPL4 RBM34 | 1.18e-05 | 655 | 115 | 11 | 35819319 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.38e-05 | 430 | 115 | 9 | 38172120 | |
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 1.42e-05 | 328 | 115 | 8 | 23398456 | |
| Pubmed | 1.55e-05 | 332 | 115 | 8 | 25693804 | ||
| Pubmed | CDK9 RPL36 RRP1B MATR3 RPS27 CSDE1 STRN4 PLCG1 PRKDC PLEC RPL3 RPL4 | 1.60e-05 | 809 | 115 | 12 | 32129710 | |
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 1.81e-05 | 47 | 115 | 4 | 29934401 | |
| Pubmed | RNPC3 NSMCE3 NCAPH KMT2C UBE2O STRN4 NKTR GFPT2 SSH2 RBM34 KIF22 | 1.88e-05 | 689 | 115 | 11 | 36543142 | |
| Pubmed | RPL36 RIOK1 UBAP2 RRP1B CDK12 MATR3 U2AF2 RPS27 CSDE1 KAT2B UBE2O RBM34 KIF22 | 2.04e-05 | 971 | 115 | 13 | 33306668 | |
| Pubmed | 2.22e-05 | 457 | 115 | 9 | 22190034 | ||
| Pubmed | MAGI3 SPOCK2 ZNF365 JPH1 ZNF512B CSDE1 UBE2O PDZD8 PLCG1 PRKDC GFPT2 PLEC USPL1 HSPA2 USP33 | 2.27e-05 | 1285 | 115 | 15 | 35914814 | |
| Pubmed | RIOK1 CARMIL1 MAGI3 RPS27 JPH1 CSDE1 XRN1 PDZD8 PRKDC RPL3 RPL4 | 2.41e-05 | 708 | 115 | 11 | 39231216 | |
| Pubmed | DSC1 TCP11L1 MATR3 U2AF2 RPS27 MYPN PRKDC PLEC NMT1 RPL3 HSPA2 TOP2A | 2.42e-05 | 844 | 115 | 12 | 25963833 | |
| Pubmed | 2.45e-05 | 103 | 115 | 5 | 32744500 | ||
| Pubmed | UBAP2 MATR3 U2AF2 KMT2C UBE2O PRKDC PLEC NMT1 RPL3 RPL4 RBM34 | 2.51e-05 | 711 | 115 | 11 | 33022573 | |
| Pubmed | 2.81e-05 | 591 | 115 | 10 | 15231748 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.81e-05 | 361 | 115 | 8 | 26167880 | |
| Pubmed | 2.81e-05 | 106 | 115 | 5 | 12429849 | ||
| Pubmed | RPL36 RRP1B MATR3 U2AF2 RPS27 CSDE1 PRKDC RPL3 RPL4 RBM34 SON | 2.99e-05 | 725 | 115 | 11 | 27025967 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.10e-05 | 477 | 115 | 9 | 31300519 | |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 3.16e-05 | 54 | 115 | 4 | 25631074 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PMS2P2 PPFIBP2 CARMIL1 TRPM2 U2AF2 MAGI3 DDX56 STK32C SFMBT2 PKNOX2 CSDE1 KMT2C ZNF608 SETBP1 PLCG1 GULP1 | 3.23e-05 | 1489 | 115 | 16 | 28611215 |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25961503 | ||
| Pubmed | Determination of the Plk4/Sak consensus phosphorylation motif using peptide spots arrays. | 3.24e-05 | 3 | 115 | 2 | 17174311 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 23629676 | ||
| Interaction | RPL13 interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NOL12 MATR3 DDX56 RPS27 NCAPH UBE2O XRN1 PDZD8 FGF11 NKTR RPL3 RPL4 TOP2A RBM34 SON | 5.13e-11 | 700 | 114 | 22 | int:RPL13 |
| Interaction | FBL interactions | ELOA SP100 RIOK1 UBAP2 DDX31 RRP1B NOP53 MATR3 U2AF2 DDX56 ZNF512B CSDE1 UBE2O ZNF644 FGF11 BRD1 NMT1 RPL3 RPL4 TOP2A RBM34 | 6.58e-11 | 639 | 114 | 21 | int:FBL |
| Interaction | RPL8 interactions | SP100 RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 MATR3 DDX56 RPS27 NCAPH PYHIN1 UBE2O XRN1 PDZD8 RPL3 RPL4 TOP2A RBM34 | 1.84e-10 | 539 | 114 | 19 | int:RPL8 |
| Interaction | RPL4 interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NOL12 MATR3 DDX56 RPS27 SRBD1 NCAPH PYHIN1 CSDE1 XRN1 PDZD8 FGF11 RPL3 RPL4 TOP2A RBM34 | 2.71e-10 | 764 | 114 | 22 | int:RPL4 |
| Interaction | RPL10A interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B NOP53 MATR3 U2AF2 RPS27 NCAPH CSDE1 UBE2O XRN1 PDZD8 RPL3 RPL4 TOP2A RBM34 | 3.01e-10 | 490 | 114 | 18 | int:RPL10A |
| Interaction | RPS6 interactions | CDK9 ELOA RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NOL12 MATR3 DDX56 RPS27 NCAPH PYHIN1 ZNF512B UBE2O XRN1 PDZD8 RPL3 RPL4 TOP2A RBM34 TP53BP2 | 5.80e-10 | 874 | 114 | 23 | int:RPS6 |
| Interaction | RPL18A interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 U2AF2 DDX56 RPS27 SRBD1 NCAPH NEDD4 PDZD8 RPL3 RPL4 RBM34 | 5.81e-10 | 447 | 114 | 17 | int:RPL18A |
| Interaction | H1-4 interactions | CDK9 SP100 RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 DDX56 PLXND1 NCAPH PYHIN1 ZNF512B XRN1 PDZD8 NMT1 RPL3 RPL4 RBM34 KIF22 | 7.34e-10 | 656 | 114 | 20 | int:H1-4 |
| Interaction | RPS24 interactions | ELOA RPL36 RIOK1 DDX31 RRP1B NOP53 U2AF2 DDX56 RPS27 NCAPH PYHIN1 UBE2O ZNF644 PDZD8 RPL3 RPL4 TOP2A RBM34 | 1.02e-09 | 529 | 114 | 18 | int:RPS24 |
| Interaction | RPL31 interactions | CDK9 ELOA RPL36 RIOK1 ERCC5 DDX31 RRP1B NOP53 NOL12 DDX56 RPS27 NCAPH ZNF512B UBE2O PDZD8 NMT1 RPL3 RPL4 TOP2A RBM34 | 1.36e-09 | 680 | 114 | 20 | int:RPL31 |
| Interaction | SRSF6 interactions | RIOK1 DDX31 RRP1B CDK12 NOP53 RNPC3 NOL12 U2AF2 DDX56 SRBD1 UBE2O XRN1 NKTR RPL3 RPL4 RBM34 SON | 3.45e-09 | 503 | 114 | 17 | int:SRSF6 |
| Interaction | ZNF330 interactions | CDK9 ELOA RIOK1 DDX31 RRP1B MTF2 NOP53 DDX56 SRBD1 ZNF512B UBE2O ZNF644 BRD1 TOP2A RBM34 KIF22 | 4.49e-09 | 446 | 114 | 16 | int:ZNF330 |
| Interaction | RPL18 interactions | CDK9 RPL36 RIOK1 MATR3 U2AF2 DDX56 RPS27 NCAPH UBE2O ZNF644 STRN4 PDZD8 FGF11 RPL3 RPL4 TOP2A RBM34 | 4.50e-09 | 512 | 114 | 17 | int:RPL18 |
| Interaction | ZNF668 interactions | RPL36 DDX31 RRP1B NOP53 NOL12 MATR3 DDX56 XRN1 RPL3 RPL4 RBM34 KIF22 | 5.96e-09 | 226 | 114 | 12 | int:ZNF668 |
| Interaction | MAGEB2 interactions | RPL36 DDX31 RRP1B CDK12 NOP53 RNPC3 NOL12 DDX56 SRBD1 XRN1 NKTR RPL3 RPL4 RBM34 | 1.10e-08 | 349 | 114 | 14 | int:MAGEB2 |
| Interaction | CHD4 interactions | ELOA DSC1 RRP1B MTF2 PDPK1 MATR3 U2AF2 DDX56 RPS27 TRAPPC8 NCAPH PYHIN1 ZNF512B UBE2O ZNF644 XRN1 PRKDC BRD1 RPL3 RPL4 TOP2A RBM34 | 1.19e-08 | 938 | 114 | 22 | int:CHD4 |
| Interaction | ZC3H18 interactions | RPL36 DSC1 RRP1B CDK12 NOP53 MATR3 U2AF2 DDX56 RPS27 NSMCE3 PYHIN1 CRACD FGF11 NKTR BRD1 NMT1 RPL3 RPL4 TOP2A RBM34 SON | 1.89e-08 | 877 | 114 | 21 | int:ZC3H18 |
| Interaction | RPL28 interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B CDK12 MATR3 DDX56 SRBD1 NCAPH ZNF644 PDZD8 RPL3 RPL4 TOP2A RBM34 | 1.89e-08 | 494 | 114 | 16 | int:RPL28 |
| Interaction | RPL26L1 interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 MATR3 SRBD1 UBE2O AUNIP BRD1 RPL3 RPL4 RBM34 | 2.12e-08 | 431 | 114 | 15 | int:RPL26L1 |
| Interaction | SRSF1 interactions | RPL36 RIOK1 DDX31 RRP1B CDK12 NELFA NOP53 NOL12 MATR3 U2AF2 DDX56 PRKDC RPL3 RPL4 TOP2A RBM34 SON | 2.19e-08 | 570 | 114 | 17 | int:SRSF1 |
| Interaction | NAA40 interactions | ELOA RIOK1 UBAP2 DSC1 CDK12 CARMIL1 MATR3 RPS27 NCAPH ZNF512B CSDE1 CRACD UBE2O XRN1 PLCG1 PRKDC NMT1 RPL3 RPL4 TOP2A TP53BP2 SON | 2.52e-08 | 978 | 114 | 22 | int:NAA40 |
| Interaction | SNRNP70 interactions | CDK9 ELOA RPL36 RIOK1 DDX31 RRP1B CDK12 RNPC3 MATR3 U2AF2 DDX56 RPS27 SRBD1 PYHIN1 CSDE1 UBE2O NKTR RPL3 RPL4 TOP2A RBM34 SON | 2.81e-08 | 984 | 114 | 22 | int:SNRNP70 |
| Interaction | RPS3A interactions | CDK9 RPL36 RIOK1 DDX31 NOP53 RNPC3 NOL12 MATR3 U2AF2 DDX56 RPS27 NCAPH NEDD4 PDZD8 RPL3 RPL4 TOP2A RBM34 | 2.83e-08 | 655 | 114 | 18 | int:RPS3A |
| Interaction | CENPA interactions | CDK9 ERCC5 DDX31 RRP1B MTF2 NOP53 DDX56 SRBD1 ZNF512B ZNF644 PRKDC TOP2A RBM34 KIF22 | 2.91e-08 | 377 | 114 | 14 | int:CENPA |
| Interaction | GTPBP4 interactions | SP100 RPL36 RIOK1 RRP1B NOP53 NOL12 MATR3 DDX56 PYHIN1 UBE2O PRKDC RPL3 HSPA2 RPL4 RBM34 | 3.05e-08 | 443 | 114 | 15 | int:GTPBP4 |
| Interaction | SIRT7 interactions | CDK9 DDX31 RRP1B NOP53 U2AF2 DDX56 CSDE1 KAT2B UBE2O SYNE2 XRN1 PRKDC PLEC RPL3 HSPA2 RPL4 TOP2A RBM34 SON | 3.58e-08 | 744 | 114 | 19 | int:SIRT7 |
| Interaction | RPL13A interactions | RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NOL12 MATR3 DDX56 RPS27 NCAPH XRN1 PDZD8 NKTR RPL3 RPL4 RBM34 | 3.71e-08 | 591 | 114 | 17 | int:RPL13A |
| Interaction | RPL7A interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 MATR3 DDX56 RPS27 NCAPH PYHIN1 UBE2O SYNE2 PDZD8 RPL3 RPL4 RBM34 | 4.89e-08 | 679 | 114 | 18 | int:RPL7A |
| Interaction | RPL23A interactions | CDK9 SP100 RPL36 RIOK1 DDX31 RRP1B NOP53 DDX56 RPS27 NCAPH PYHIN1 UBE2O PDZD8 NMT1 RPL3 RPL4 RBM34 | 5.33e-08 | 606 | 114 | 17 | int:RPL23A |
| Interaction | RPL14 interactions | RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NOL12 MATR3 DDX56 RPS27 NCAPH XRN1 RPL3 RPL4 TOP2A RBM34 | 9.20e-08 | 554 | 114 | 16 | int:RPL14 |
| Interaction | RPL19 interactions | SP100 RPL36 RIOK1 DDX31 NOP53 NOL12 RPS27 NCAPH PYHIN1 UBE2O PDZD8 FGF11 NMT1 RPL3 RPL4 TOP2A RBM34 | 1.11e-07 | 638 | 114 | 17 | int:RPL19 |
| Interaction | DGCR8 interactions | DDX31 RRP1B CDK12 NOP53 U2AF2 DDX56 UBE2O PRKDC RPL3 RPL4 RBM34 | 1.29e-07 | 242 | 114 | 11 | int:DGCR8 |
| Interaction | HECTD1 interactions | ELOA DDX31 RRP1B CDK12 NOP53 RNPC3 MATR3 U2AF2 DDX56 RPS27 SRBD1 NCAPH CSDE1 XRN1 PRKDC SSH2 RPL4 TOP2A RBM34 SON KIF22 | 1.33e-07 | 984 | 114 | 21 | int:HECTD1 |
| Interaction | RPL36 interactions | RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NCAPH PYHIN1 UBE2O PDZD8 NKTR RPL3 RPL4 TOP2A RBM34 | 1.64e-07 | 504 | 114 | 15 | int:RPL36 |
| Interaction | RPL7L1 interactions | 2.36e-07 | 203 | 114 | 10 | int:RPL7L1 | |
| Interaction | RPA4 interactions | RPL36 ERCC5 UBAP2 MATR3 U2AF2 RPS27 NCAPH CSDE1 STRN4 RPL3 RPL4 TOP2A TP53BP2 SON | 2.70e-07 | 452 | 114 | 14 | int:RPA4 |
| Interaction | MEN1 interactions | CDK9 RPL36 UBAP2 DDX31 RRP1B NOP53 NOL12 MATR3 U2AF2 DDX56 SRBD1 ZNF512B KMT2C ZNF608 ZNF644 SETBP1 RPL3 RPL4 TOP2A RBM34 SON | 2.80e-07 | 1029 | 114 | 21 | int:MEN1 |
| Interaction | RPL15 interactions | CDK9 RPL36 RIOK1 CDK12 MATR3 U2AF2 RPS27 NCAPH UBE2O PDZD8 NKTR RPL3 RPL4 TOP2A RBM34 | 3.11e-07 | 530 | 114 | 15 | int:RPL15 |
| Interaction | RPL37A interactions | RPL36 DDX31 CDK12 NOP53 U2AF2 DDX56 NCAPH UBE2O SYNE2 PDZD8 RPL3 RPL4 RBM34 | 3.34e-07 | 391 | 114 | 13 | int:RPL37A |
| Interaction | CIT interactions | CDK9 GAD1 RPL36 DDX31 RRP1B NOP53 MATR3 U2AF2 MAGI3 DDX56 PLXND1 SRBD1 SYT10 PYHIN1 NBAS SYNE2 NKTR PRKDC SSH2 PLEC RPL3 HSPA2 RPL4 TOP2A SON | 4.21e-07 | 1450 | 114 | 25 | int:CIT |
| Interaction | RPL10 interactions | RPL36 RIOK1 DDX31 NOP53 MATR3 DDX56 RPS27 NCAPH PYHIN1 UBE2O PDZD8 BRD1 RPL3 RPL4 TOP2A RBM34 KIF22 | 4.29e-07 | 702 | 114 | 17 | int:RPL10 |
| Interaction | RPL30 interactions | CDK9 RPL36 RIOK1 DDX31 NOP53 DDX56 RPS27 NCAPH XRN1 PDZD8 RPL3 RPL4 TOP2A RBM34 | 4.79e-07 | 474 | 114 | 14 | int:RPL30 |
| Interaction | SRSF5 interactions | RPL36 RIOK1 DDX31 CDK12 NOP53 NOL12 U2AF2 MAGI3 DDX56 UBE2O RPL3 RPL4 RBM34 SON | 4.79e-07 | 474 | 114 | 14 | int:SRSF5 |
| Interaction | RSL1D1 interactions | RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 MATR3 PYHIN1 RHOQ UBE2O NKTR RPL3 RPL4 RBM34 | 5.42e-07 | 479 | 114 | 14 | int:RSL1D1 |
| Interaction | MYCN interactions | RPL36 DDX31 DSC1 RRP1B CDK12 NOP53 NOL12 MATR3 U2AF2 RNF13 RPS27 ODC1 SRBD1 NEDD4 ZNF512B CSDE1 KAT2B PRKDC RPL3 HSPA2 RPL4 RBM34 UQCRFS1P1 SON | 5.88e-07 | 1373 | 114 | 24 | int:MYCN |
| Interaction | NHLH1 interactions | 6.70e-07 | 88 | 114 | 7 | int:NHLH1 | |
| Interaction | NOP2 interactions | CDK9 RPL36 DDX31 CDK12 NOP53 NOL12 MATR3 DDX56 FGF11 RPL3 RPL4 TOP2A RBM34 | 6.73e-07 | 416 | 114 | 13 | int:NOP2 |
| Interaction | H3C1 interactions | CDK9 ELOA RPL36 RIOK1 DDX31 RRP1B SRBD1 ZNF512B KMT2C KAT2B CCNB3 ZNF644 PRKDC BRD1 RPL3 TOP2A RBM34 JHY KIF22 | 6.87e-07 | 901 | 114 | 19 | int:H3C1 |
| Interaction | MECP2 interactions | CDK9 ELOA SP100 RPL36 DDX31 RRP1B CDK12 RNPC3 NOL12 MATR3 U2AF2 SPOCK2 DDX56 SRBD1 DCX PYHIN1 ZNF512B NKTR PRKDC PLEC RPL3 RPL4 SON | 7.22e-07 | 1287 | 114 | 23 | int:MECP2 |
| Interaction | RPS8 interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NOL12 DDX56 RPS27 NCAPH PDZD8 RPL3 RPL4 TOP2A RBM34 | 7.67e-07 | 649 | 114 | 16 | int:RPS8 |
| Interaction | ABT1 interactions | RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 NOL12 DDX56 SRBD1 UBE2O RPL3 RPL4 RBM34 | 8.11e-07 | 423 | 114 | 13 | int:ABT1 |
| Interaction | H2BC8 interactions | ELOA RIOK1 ERCC5 DDX31 MTF2 NELFA DDX56 SRBD1 ZNF512B UBE2O ZNF644 BRD1 TOP2A RBM34 KIF22 | 8.89e-07 | 576 | 114 | 15 | int:H2BC8 |
| Interaction | RPS2 interactions | CDK9 RPL36 RIOK1 NOP53 NOL12 MATR3 DDX56 RPS27 NCAPH PYHIN1 UBE2O PDZD8 RPL3 RPL4 TOP2A RBM34 | 9.01e-07 | 657 | 114 | 16 | int:RPS2 |
| Interaction | RPLP0 interactions | CDK9 RPL36 RIOK1 DDX31 RRP1B CDK12 NOP53 DDX56 RPS27 NCAPH UBE2O XRN1 PDZD8 RPL3 RPL4 RBM34 | 9.57e-07 | 660 | 114 | 16 | int:RPLP0 |
| Interaction | LHX2 interactions | 9.85e-07 | 183 | 114 | 9 | int:LHX2 | |
| Interaction | PARP1 interactions | CDK9 ELOA UBAP2 DDX31 RRP1B MTF2 NOP53 U2AF2 DDX56 SRBD1 NCAPH ZNF365 PYHIN1 ZNF512B KAT2B UBE2O ZNF644 PRKDC RPL3 HSPA2 TOP2A RBM34 KIF22 | 1.06e-06 | 1316 | 114 | 23 | int:PARP1 |
| Interaction | TNIP1 interactions | ELOA RPL36 RIOK1 DSC1 RRP1B NOP53 NOL12 MATR3 U2AF2 DDX56 RPS27 JPH1 CSDE1 PRKDC GFPT2 PLEC RPL3 HSPA2 RPL4 TOP2A SON KIF22 | 1.09e-06 | 1217 | 114 | 22 | int:TNIP1 |
| Interaction | EIF6 interactions | RPL36 DDX31 RRP1B NOP53 DDX56 NEDD4 FGF11 RPL3 RPL4 TOP2A RBM34 USP33 | 1.09e-06 | 365 | 114 | 12 | int:EIF6 |
| Interaction | CHD3 interactions | ELOA RPL36 RIOK1 RRP1B MTF2 MATR3 U2AF2 DDX56 RPS27 ZNF512B PRKDC BRD1 RPL3 RPL4 PLK4 TOP2A RBM34 | 1.21e-06 | 757 | 114 | 17 | int:CHD3 |
| Interaction | RC3H1 interactions | RPL36 RIOK1 RRP1B CDK12 MATR3 U2AF2 DDX56 RPS27 SRBD1 NCAPH CSDE1 XRN1 RPL3 HSPA2 RPL4 RBM34 | 1.33e-06 | 677 | 114 | 16 | int:RC3H1 |
| Interaction | SRPK3 interactions | 1.35e-06 | 190 | 114 | 9 | int:SRPK3 | |
| Interaction | PRPF19 interactions | ELOA RIOK1 ERCC5 U2AF2 NCAPH UBE2O STRN4 FGF11 NKTR PRKDC TOP2A TP53BP2 SON | 1.62e-06 | 450 | 114 | 13 | int:PRPF19 |
| Interaction | KRR1 interactions | RIOK1 DDX31 RRP1B NOP53 NOL12 DDX56 UBE2O PLEC RPL3 RPL4 RBM34 USP33 | 1.62e-06 | 379 | 114 | 12 | int:KRR1 |
| Interaction | RPL27A interactions | CDK9 RPL36 RIOK1 DDX31 RPS27 SRBD1 NCAPH UBE2O PDZD8 FGF11 RPL3 RPL4 TOP2A | 2.01e-06 | 459 | 114 | 13 | int:RPL27A |
| Interaction | CCDC137 interactions | 2.06e-06 | 200 | 114 | 9 | int:CCDC137 | |
| Interaction | RRP8 interactions | 2.18e-06 | 259 | 114 | 10 | int:RRP8 | |
| Interaction | NPM3 interactions | 2.41e-06 | 262 | 114 | 10 | int:NPM3 | |
| Interaction | RBM4B interactions | 2.41e-06 | 262 | 114 | 10 | int:RBM4B | |
| Interaction | IFI16 interactions | ELOA SP100 RIOK1 RRP1B NOP53 MATR3 U2AF2 DDX56 SRBD1 XRN1 BRD1 RPL3 RPL4 TOP2A RBM34 SON | 2.65e-06 | 714 | 114 | 16 | int:IFI16 |
| Interaction | SRPK2 interactions | CDK9 DDX31 RRP1B CDK12 NOP53 RNPC3 MATR3 U2AF2 DDX56 PYHIN1 NKTR RPL3 RPL4 TOP2A RBM34 SON | 2.80e-06 | 717 | 114 | 16 | int:SRPK2 |
| Interaction | COIL interactions | CDK9 ELOA RIOK1 DDX31 NELFA DDX56 RPS27 SRBD1 ZNF512B ZNF644 USPL1 RPL3 TOP2A RBM34 | 2.88e-06 | 552 | 114 | 14 | int:COIL |
| Interaction | RPL3 interactions | RPL36 RIOK1 DDX31 RRP1B NOP53 MATR3 DDX56 RPS27 NCAPH XRN1 PDZD8 FGF11 RPL3 RPL4 TOP2A RBM34 | 3.06e-06 | 722 | 114 | 16 | int:RPL3 |
| Interaction | SNRNP40 interactions | DDX31 RRP1B CDK12 NOP53 RNPC3 U2AF2 DDX56 SRBD1 ZNF608 ZNF644 PDZD8 NKTR RPL3 TOP2A SON | 3.08e-06 | 637 | 114 | 15 | int:SNRNP40 |
| Interaction | RPS16 interactions | CDK9 RPL36 RIOK1 RRP1B NOL12 DDX56 RPS27 SRBD1 NCAPH XRN1 PDZD8 NMT1 RPL3 RPL4 TOP2A SON | 3.17e-06 | 724 | 114 | 16 | int:RPS16 |
| Interaction | RPS19 interactions | CDK9 SP100 RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 DDX56 RPS27 NCAPH UBE2O PDZD8 RPL3 RPL4 | 3.20e-06 | 639 | 114 | 15 | int:RPS19 |
| Interaction | RPL35 interactions | RPL36 RIOK1 DDX31 RRP1B NOP53 DDX56 RPS27 NCAPH UBE2O PDZD8 RPL3 RPL4 TOP2A RBM34 | 3.26e-06 | 558 | 114 | 14 | int:RPL35 |
| Interaction | NPM1 interactions | CDK9 RPL36 DDX31 RRP1B NOP53 NOL12 U2AF2 DDX56 RPS27 NCAPH SYNE2 PDZD8 PLCG1 PRKDC BRD1 RPL3 RPL4 TOP2A RBM34 SON KIF22 | 3.36e-06 | 1201 | 114 | 21 | int:NPM1 |
| Interaction | ADARB1 interactions | DDX31 RRP1B CDK12 NOP53 NOL12 U2AF2 DDX56 NKTR PLEC RPL3 RPL4 TOP2A RBM34 | 4.02e-06 | 489 | 114 | 13 | int:ADARB1 |
| Interaction | RPL11 interactions | RPL36 RIOK1 DDX31 RRP1B NOP53 NOL12 DDX56 RPS27 NCAPH UBE2O PDZD8 RPL3 RPL4 TOP2A RBM34 | 4.08e-06 | 652 | 114 | 15 | int:RPL11 |
| Interaction | RPL7 interactions | CDK9 RPL36 RIOK1 CDK12 NOP53 MATR3 RPS27 NCAPH PYHIN1 PDZD8 RPL3 RPL4 TOP2A | 4.20e-06 | 491 | 114 | 13 | int:RPL7 |
| Interaction | RRS1 interactions | CDK9 RPL36 RRP1B CDK12 NOP53 MATR3 U2AF2 DDX56 RPL3 RPL4 RBM34 | 4.22e-06 | 345 | 114 | 11 | int:RRS1 |
| Interaction | CCDC140 interactions | 4.57e-06 | 117 | 114 | 7 | int:CCDC140 | |
| Interaction | H3C3 interactions | ELOA RIOK1 DDX31 RRP1B MTF2 SRBD1 ZNF512B UBE2O ZNF644 BRD1 TOP2A RBM34 KIF22 | 4.58e-06 | 495 | 114 | 13 | int:H3C3 |
| Interaction | RPL29 interactions | 4.64e-06 | 282 | 114 | 10 | int:RPL29 | |
| Interaction | WWP2 interactions | CDK9 RPL36 UBAP2 RRP1B NELFA MATR3 U2AF2 RPS27 SRBD1 CSDE1 RHOQ PRKDC RPL3 RPL4 TOP2A RBM34 TP53BP2 | 4.92e-06 | 840 | 114 | 17 | int:WWP2 |
| Interaction | PURG interactions | 5.02e-06 | 223 | 114 | 9 | int:PURG | |
| Interaction | RPS11 interactions | CDK9 RPL36 RIOK1 MATR3 DDX56 RPS27 NCAPH UBE2O PRKDC BRD1 RPL3 RPL4 TOP2A | 5.69e-06 | 505 | 114 | 13 | int:RPS11 |
| Interaction | TMPO interactions | CDK9 MATR3 U2AF2 NCAPH PYHIN1 JPH1 RHOQ NBAS UBE2O SYNE2 PDZD8 PRKDC BRD1 RPL3 RPL4 USP33 | 6.06e-06 | 762 | 114 | 16 | int:TMPO |
| Interaction | YWHAG interactions | CDK9 UBAP2 CDK12 PPFIBP2 PDPK1 CARMIL1 MATR3 MAGI3 RPS27 DNAH7 NEDD4 PYHIN1 CRACD SYNE2 NKTR PRKDC SSH2 BRD1 PLK4 TP53BP2 SON | 6.10e-06 | 1248 | 114 | 21 | int:YWHAG |
| Interaction | RNF151 interactions | 6.37e-06 | 123 | 114 | 7 | int:RNF151 | |
| Interaction | RPS9 interactions | CDK9 RPL36 RIOK1 NOP53 MATR3 DDX56 RPS27 NCAPH PDZD8 RPL3 RPL4 TOP2A RBM34 | 7.03e-06 | 515 | 114 | 13 | int:RPS9 |
| Interaction | USP36 interactions | ELOA RPL36 DDX31 RRP1B NOP53 NOL12 DDX56 NEDD4 PRKDC RPL3 HSPA2 RPL4 TOP2A RBM34 | 7.34e-06 | 599 | 114 | 14 | int:USP36 |
| Interaction | RPSA interactions | CDK9 RPL36 RIOK1 DDX31 NOP53 NOL12 RPS27 NCAPH NEDD4 UBE2O PDZD8 RPL3 RPL4 | 8.12e-06 | 522 | 114 | 13 | int:RPSA |
| Interaction | SENP3 interactions | 8.23e-06 | 301 | 114 | 10 | int:SENP3 | |
| Interaction | RPL5 interactions | RPL36 RIOK1 RRP1B NOP53 DDX56 RPS27 NCAPH UBE2O XRN1 PDZD8 RPL3 RPL4 RBM34 SON | 8.37e-06 | 606 | 114 | 14 | int:RPL5 |
| Interaction | LYAR interactions | ELOA RIOK1 DDX31 NOP53 NOL12 DDX56 PYHIN1 BRD1 RPL3 RPL4 RBM34 | 8.83e-06 | 373 | 114 | 11 | int:LYAR |
| Interaction | NUP43 interactions | ERCC5 DDX31 DSC1 RRP1B CDK12 NOP53 ZNF608 ZNF644 SYNE2 NKTR RPL3 TOP2A SON AFG1L | 1.18e-05 | 625 | 114 | 14 | int:NUP43 |
| Interaction | CTCF interactions | SP100 RPL36 RRP1B NOP53 U2AF2 RPS27 PYHIN1 PRKDC BRD1 RPL3 RPL4 TOP2A | 1.19e-05 | 461 | 114 | 12 | int:CTCF |
| Interaction | DOT1L interactions | CDK9 RPL36 UBAP2 DDX31 RRP1B NOP53 NOL12 MATR3 DDX56 RPS27 ZNF512B PRKDC RPL3 TOP2A RBM34 SON | 1.24e-05 | 807 | 114 | 16 | int:DOT1L |
| Interaction | YWHAH interactions | CDK9 UBAP2 PPFIBP2 PDPK1 CARMIL1 MATR3 MAGI3 RPS27 DNAH7 NEDD4 PYHIN1 SYNE2 XRN1 NKTR SSH2 PLEC BRD1 PLK4 TP53BP2 | 1.28e-05 | 1102 | 114 | 19 | int:YWHAH |
| GeneFamily | PHD finger proteins | 3.46e-04 | 90 | 67 | 4 | 88 | |
| GeneFamily | L ribosomal proteins | 8.92e-04 | 51 | 67 | 3 | 729 | |
| Coexpression | KIM_WT1_TARGETS_8HR_UP | 9.24e-06 | 167 | 115 | 7 | M8857 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 2.29e-05 | 77 | 115 | 5 | M40001 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | OSTM1 NOP53 MATK MATR3 SPOCK2 RPS27 ODC1 TRAPPC8 SFMBT2 PYHIN1 CSDE1 KMT2C KAT2B ZNF644 XRN1 PLCG1 SSH2 RPL4 SON | 2.59e-05 | 1492 | 115 | 19 | M40023 |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_DN | 2.78e-05 | 198 | 115 | 7 | M3121 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B1_BCELL_UP | 2.96e-05 | 200 | 115 | 7 | M6466 | |
| Coexpression | WIERENGA_PML_INTERACTOME | 3.46e-05 | 42 | 115 | 4 | M2219 | |
| Coexpression | GOLDRATH_ANTIGEN_RESPONSE | 3.50e-05 | 366 | 115 | 9 | M11884 | |
| Coexpression | GOLDRATH_ANTIGEN_RESPONSE | 6.56e-05 | 397 | 115 | 9 | MM1255 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | OSTM1 MATR3 RNF13 TRAPPC8 CSDE1 RHOQ CRACD KMT2C KAT2B SETBP1 SYNE2 PDZD8 RPL3 RPL4 | 6.98e-05 | 946 | 115 | 14 | M39169 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | UBAP2 MATR3 FANCM NCAPH TYW1B CTNNA3 PRKDC RPL3 RPL4 PLK4 TOP2A KIF22 | 7.26e-05 | 714 | 115 | 12 | M1744 |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | 9.71e-05 | 418 | 115 | 9 | MM3752 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOK5 SP100 MTF2 RNF13 TRAPPC8 MBOAT2 NEDD4 NBAS MGAT5 SYNE2 TOP2A TP53BP2 SON | 9.97e-05 | 856 | 115 | 13 | M4500 |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 1.00e-04 | 327 | 115 | 8 | MM3714 | |
| Coexpression | ZHANG_UTERUS_C8_NK_CELL | 1.00e-04 | 168 | 115 | 6 | MM16614 | |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_UP | 1.21e-04 | 174 | 115 | 6 | M8186 | |
| Coexpression | OSMAN_BLADDER_CANCER_DN | 1.22e-04 | 431 | 115 | 9 | M16858 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.24e-04 | 432 | 115 | 9 | M41149 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | 1.38e-04 | 438 | 115 | 9 | M227 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | RPL36 OSTM1 NOP53 MATR3 SPOCK2 RPS27 SFMBT2 SYNE2 NKTR PRKDC RPL3 RPL4 SON | 1.84e-04 | 911 | 115 | 13 | M40038 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.05e-04 | 363 | 115 | 8 | M41103 | |
| Coexpression | FUJII_YBX1_TARGETS_DN | 2.19e-04 | 194 | 115 | 6 | M14340 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_DN | 2.26e-04 | 195 | 115 | 6 | M3117 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 2.45e-04 | 198 | 115 | 6 | M3171 | |
| Coexpression | HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP | 2.49e-04 | 28 | 115 | 3 | M2553 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 2.52e-04 | 199 | 115 | 6 | M4494 | |
| Coexpression | GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP | 2.52e-04 | 199 | 115 | 6 | M3052 | |
| Coexpression | GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP | 2.52e-04 | 199 | 115 | 6 | M3050 | |
| Coexpression | CROONQUIST_NRAS_SIGNALING_DN | 2.58e-04 | 70 | 115 | 4 | M10739 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M6473 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP | 2.58e-04 | 200 | 115 | 6 | M5280 | |
| Coexpression | GSE27786_NKCELL_VS_MONO_MAC_UP | 2.58e-04 | 200 | 115 | 6 | M4860 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 2.58e-04 | 200 | 115 | 6 | M5901 | |
| Coexpression | GSE1460_DP_VS_CD4_THYMOCYTE_DN | 2.58e-04 | 200 | 115 | 6 | M3454 | |
| Coexpression | GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN | 2.58e-04 | 200 | 115 | 6 | M6781 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_DN | 2.58e-04 | 200 | 115 | 6 | M5746 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M3036 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M7431 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 2.58e-04 | 200 | 115 | 6 | M8765 | |
| Coexpression | TRAVAGLINI_LUNG_CD8_MEMORY_EFFECTOR_T_CELL | 2.77e-04 | 29 | 115 | 3 | M41681 | |
| Coexpression | TRAVAGLINI_LUNG_CD4_NAIVE_T_CELL | 2.96e-04 | 132 | 115 | 5 | M41684 | |
| ToppCell | ASK454-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.79e-09 | 193 | 114 | 9 | 11e1db416dc9a0b99ddb72d6021fba6e25405b5c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.05e-09 | 196 | 114 | 9 | c647ce58de4c5bb4ceb1123690e637eae4ae1b82 | |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | 2.24e-09 | 198 | 114 | 9 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.35e-09 | 199 | 114 | 9 | 87806883330ad56cf1dfd564734c0c1b64152e7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-09 | 199 | 114 | 9 | 3003badee037d4d63a8018a74c0aea213d049e43 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-08 | 167 | 114 | 8 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | control-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.35e-08 | 182 | 114 | 8 | 8e96a9dd70814cb0925776613b3a12026d455cad | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-08 | 183 | 114 | 8 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-08 | 183 | 114 | 8 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | Healthy_donor-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 3.55e-08 | 192 | 114 | 8 | 1603903454ba6bf65c8e13ede620e0b1e8fbd7ec | |
| ToppCell | ASK454-Immune-T_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.70e-08 | 193 | 114 | 8 | 27c38a364bcdb4c0967155f18aa81d37e17c920b | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.01e-08 | 195 | 114 | 8 | 90136f65e3e72cf2b2e0a13b48a7c9d60628b396 | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 4.01e-08 | 195 | 114 | 8 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.01e-08 | 195 | 114 | 8 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.17e-08 | 196 | 114 | 8 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.34e-08 | 197 | 114 | 8 | 53fc73dcf93403251b5d519aa6fcfbff7240015f | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.34e-08 | 197 | 114 | 8 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.51e-08 | 198 | 114 | 8 | 24f6954aff8751885e783d68c631b04dd1980f48 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.51e-08 | 198 | 114 | 8 | 5024d43b4cf7dea305ed911f1e123ca7fd44e990 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.51e-08 | 198 | 114 | 8 | 4633e379893a26a746f8e29302cc54bbe04dd23f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.51e-08 | 198 | 114 | 8 | f77f21f21566a04145217ebf85cd14db48945056 | |
| ToppCell | T/NK_cells|World / Lineage and Cell class | 4.51e-08 | 198 | 114 | 8 | c11f69b22a1ae0b371e9d0f0999716c945d0929d | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK|COVID-19_Convalescent / Disease group, lineage and cell class | 4.51e-08 | 198 | 114 | 8 | 457ba9e3f1bb6453af8cc1a6e7436af66296f8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.51e-08 | 198 | 114 | 8 | 7f61a9a3d61992c023cc4bc4571a0a7a1a160833 | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.51e-08 | 198 | 114 | 8 | 2cd13418396ab2c53b1be96e7795841c2482bfca | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.51e-08 | 198 | 114 | 8 | ab17003f5dddc495aa7e1bfb84df66cd2f9113c3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.51e-08 | 198 | 114 | 8 | d3d117dc3c2a533365bd2d1a6ab0c60e976d2c10 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.51e-08 | 198 | 114 | 8 | ed39ac9d4b1f50e9086ace3ad3325db0d5f4c323 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.69e-08 | 199 | 114 | 8 | 55a53949fac7534aa83cfc845131e02032eec5f7 | |
| ToppCell | mild-Lymphocytic|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.69e-08 | 199 | 114 | 8 | 57a429b4c98decbd0bffb67733eaae1f907898a3 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 4.69e-08 | 199 | 114 | 8 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.69e-08 | 199 | 114 | 8 | 4366ead68736ae3a2cefac71fd349d526cccb611 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.87e-08 | 200 | 114 | 8 | 73b91cb66c375b44e852404a4a445cf2b9595aee | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK|Multiple_Sclerosis / Disease, condition lineage and cell class | 4.87e-08 | 200 | 114 | 8 | a0644cfaeeebe6428234daef692f1f3634d0108a | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK|COVID-19_Severe / Disease group, lineage and cell class | 4.87e-08 | 200 | 114 | 8 | 9fc818bf5c9133fc2fece47980e71fd3f8603558 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 4.87e-08 | 200 | 114 | 8 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_CTL|COVID-19_Mild / Disease, condition lineage and cell class | 4.87e-08 | 200 | 114 | 8 | 11fd7eca2fa399ec3d7f9556d09e07c886cc9e83 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.87e-08 | 200 | 114 | 8 | f1c8780d64b58b6fb84fffbc27f0ad337b1a6e56 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-07 | 160 | 114 | 7 | 6b5b5aa12f0d00757728f5597f569d68406d6f56 | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TCM|Control / Disease, Lineage and Cell Type | 3.60e-07 | 176 | 114 | 7 | 1a7948eb86ee1da607db4d0576312b2859d94523 | |
| ToppCell | Healthy-CD8+_T_naive|World / disease group, cell group and cell class | 4.51e-07 | 182 | 114 | 7 | b7d9f02c29c92c8803e11f967ad6eea032cb4224 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-07 | 182 | 114 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.41e-07 | 187 | 114 | 7 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_TCM|Control / Disease, Lineage and Cell Type | 5.41e-07 | 187 | 114 | 7 | 1de80f40f753b31aed1fac9f3ff8a2ee6c755eec | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_TCM|ICU-NoSEP / Disease, Lineage and Cell Type | 5.41e-07 | 187 | 114 | 7 | 9856e0ddf989707e2a25ed6ab75bd9fa939c9046 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.41e-07 | 187 | 114 | 7 | dda43cc4983f1c11a2258bbce9f805db4125322c | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_TCM|Int-URO / Disease, Lineage and Cell Type | 5.41e-07 | 187 | 114 | 7 | 9a137961d33c6b440f1e5ef40360a365e3c03ab2 | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD4+_T|normal_Lung / Location, Cell class and cell subclass | 5.82e-07 | 189 | 114 | 7 | 4587d9b610e71698bb749fe1809c6210f93fecfc | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 6.03e-07 | 190 | 114 | 7 | 5f8d606d2f465ddeae7451835f84b3f25a151d2a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.06e-07 | 118 | 114 | 6 | e5202fadb3f9d91e56337ddad1666196ec748d87 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.24e-07 | 191 | 114 | 7 | 7ad9b7a77d8a803011306a7f716f62b19b7dc556 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.24e-07 | 191 | 114 | 7 | 913cbdd370e0bcc57038dc4c78a4b6d7ac420b5d | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_CTL|COVID-19_Severe / Disease group, lineage and cell class | 6.24e-07 | 191 | 114 | 7 | ca138cc2224b32dd08cf98ead00188bcfb1a9b69 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.24e-07 | 191 | 114 | 7 | b96233056cab384f34f804f4d767d0f98a280861 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.24e-07 | 191 | 114 | 7 | 53131efa8486abeb40e53f1dcf7c2d779f60f8cb | |
| ToppCell | ILEUM-inflamed-(1)_Central_Memory_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.69e-07 | 193 | 114 | 7 | c4975fff8927649669e93d3e04308cbf4a48e3e9 | |
| ToppCell | ASK428-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.69e-07 | 193 | 114 | 7 | bca9bf941193feea8ed56735041513185c165135 | |
| ToppCell | Healthy/Control-CD4+_Tcm|World / Disease group and Cell class | 6.93e-07 | 194 | 114 | 7 | cbdd1786305108cbeddea07a21120067d78c59a0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.93e-07 | 194 | 114 | 7 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | critical-Lymphoid-NKT|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.93e-07 | 194 | 114 | 7 | 6d47bb99157943fd1283f2e1bfa163ebe08c5a26 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.93e-07 | 194 | 114 | 7 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | T/NK_cells-Regulatory_T_cell|World / Lineage and Cell class | 6.93e-07 | 194 | 114 | 7 | 4f55da763f63d1bf6379582e9d85796a797c5b76 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.93e-07 | 194 | 114 | 7 | 1600ed112cec4ad05469b4aa5647314a8691575c | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 6.93e-07 | 194 | 114 | 7 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.17e-07 | 195 | 114 | 7 | 4e114f6399863406bd87220dea7fb7dfd08824bd | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.17e-07 | 195 | 114 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.17e-07 | 195 | 114 | 7 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.17e-07 | 195 | 114 | 7 | f2693586c9e3c2ad1b5776f319b0b60e0c19628e | |
| ToppCell | normal_Pleural_Fluid|World / Location, Cell class and cell subclass | 7.42e-07 | 196 | 114 | 7 | 7029c9f4a826f6cfdcb5f7a472fba94e8945a771 | |
| ToppCell | Healthy-CD4+_Tcm|World / disease group, cell group and cell class | 7.42e-07 | 196 | 114 | 7 | cf19bc920f3ef07a87a2cdcb43f9f5855ef1fa9a | |
| ToppCell | Healthy-CD4+_CTL|World / disease group, cell group and cell class | 7.42e-07 | 196 | 114 | 7 | 6a623eeb2ba8d4e16543820bcbba41eecbd00ed2 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Trm/em_CD8|Lung / Manually curated celltypes from each tissue | 7.42e-07 | 196 | 114 | 7 | cbb63b9ea85b2060e90dd551aa4e697b3f1494fc | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 7.42e-07 | 196 | 114 | 7 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | BLOOD--(1)_T_cell| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.42e-07 | 196 | 114 | 7 | 9dda5d10f1eecf5322cae467e337e2fb92d8e3a1 | |
| ToppCell | Healthy/Control-gd_T|World / Disease group and Cell class | 7.42e-07 | 196 | 114 | 7 | b982c84552e7efbff2be861f0f569f40804f5d88 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.68e-07 | 197 | 114 | 7 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.68e-07 | 197 | 114 | 7 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.68e-07 | 197 | 114 | 7 | c842d169dfce9af3ed7c01dc7e940c0bdd21388c | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.68e-07 | 197 | 114 | 7 | b4f801cd48955463285e0c1bb4fc8ea790c631cb | |
| ToppCell | critical-Lymphoid|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.68e-07 | 197 | 114 | 7 | a3b612591f4f1d59aaa305195e224c2bd69c5d53 | |
| ToppCell | Healthy_donor-CD4+_CTL|World / disease group, cell group and cell class (v2) | 7.68e-07 | 197 | 114 | 7 | 1dee9b905ef36e567acc1094a3c0e41f56d1261e | |
| ToppCell | control-Lymphocytic-CD8_T_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.68e-07 | 197 | 114 | 7 | c1c47db5e8d1b248bc192556275edd1ce168a953 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|normal_Lung / Location, Cell class and cell subclass | 7.68e-07 | 197 | 114 | 7 | 559b22ff973a1551e614a972085343e7d8e8a668 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_1|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.68e-07 | 197 | 114 | 7 | 821c1df511cc4a286ddc6fa229059561f6f6bade | |
| ToppCell | BL-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.95e-07 | 198 | 114 | 7 | 1c0227e58a64c0bf509bfb9578fb91277316b120 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.95e-07 | 198 | 114 | 7 | 1fa0ea06453d6b979039f63454e7f9c69323a350 | |
| ToppCell | mild|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.95e-07 | 198 | 114 | 7 | 3cef2e13d5ec71bb265171239980697a2560fa30 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class | 7.95e-07 | 198 | 114 | 7 | cb584f7754ef4e6d9ec7155022852f2d2676ab4f | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK|Bac-SEP / Disease, Lineage and Cell Type | 7.95e-07 | 198 | 114 | 7 | 6dc8d9272218784df2365863f50eb30d07ab8fef | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.95e-07 | 198 | 114 | 7 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | severe-Lymphocytic|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.95e-07 | 198 | 114 | 7 | 7b85f763a5f5fb7bed8e0d702364a2dd18a74f7d | |
| ToppCell | (2)_NK/T|World / immune cells in Peripheral Blood (logTPM normalization) | 7.95e-07 | 198 | 114 | 7 | 3156d26d9a153f594e140cdb04c55b9527747ef0 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.95e-07 | 198 | 114 | 7 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_3|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.95e-07 | 198 | 114 | 7 | 667b2a046c9db3be2f2855f658343a56ad9ad32d | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.22e-07 | 199 | 114 | 7 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | control-Lymphocytic|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.22e-07 | 199 | 114 | 7 | 3437cb814d00758109c4af37f30e0f9088e94147 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.22e-07 | 199 | 114 | 7 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.22e-07 | 199 | 114 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | distal-Hematologic-CD8+_Memory/Effector_T-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.22e-07 | 199 | 114 | 7 | a2f54e56013ec2c83407fdb3fcbe5d10d146cca4 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.50e-07 | 200 | 114 | 7 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.29e-06 | 193 | 115 | 8 | 6967_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 6.29e-06 | 193 | 115 | 8 | 7097_UP | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A | 7.59e-06 | 198 | 115 | 8 | 1913_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 7.87e-06 | 199 | 115 | 8 | 5817_DN | |
| Disease | Adenoid Cystic Carcinoma | 4.07e-05 | 100 | 112 | 5 | C0010606 | |
| Disease | response to peginterferon alfa-2a | 1.15e-04 | 25 | 112 | 3 | EFO_0010103 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 3.94e-04 | 8 | 112 | 2 | DOID:0050425 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 4.99e-04 | 96 | 112 | 4 | C1319315 | |
| Disease | IGF-1 measurement | 5.60e-04 | 488 | 112 | 8 | EFO_0004627 | |
| Disease | psoriasis | 6.26e-04 | 273 | 112 | 6 | EFO_0000676 | |
| Disease | left ventricular diastolic function measurement | 1.15e-03 | 54 | 112 | 3 | EFO_0008204 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.40e-03 | 215 | 112 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.55e-03 | 220 | 112 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | Global developmental delay | 1.68e-03 | 133 | 112 | 4 | C0557874 | |
| Disease | Bipolar Disorder | 2.33e-03 | 477 | 112 | 7 | C0005586 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 2.34e-03 | 19 | 112 | 2 | EFO_0003100, GO_1902519 | |
| Disease | leukemia (implicated_via_orthology) | 2.34e-03 | 19 | 112 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | 2.53e-03 | 619 | 112 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | nucleotide measurement | 2.73e-03 | 73 | 112 | 3 | EFO_0010513 | |
| Disease | disease | 2.86e-03 | 21 | 112 | 2 | EFO_0000408 | |
| Disease | HDL cholesterol change measurement | 3.73e-03 | 24 | 112 | 2 | EFO_0007805 | |
| Disease | white matter microstructure measurement | 3.79e-03 | 390 | 112 | 6 | EFO_0005674 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RHKNNRVKKKNEALP | 91 | O95696 | |
| SKPVKKEKEQRTRHL | 651 | Q9NYV4 | |
| HKRIHRLKQSLPKRK | 171 | Q8WV93 | |
| SAQRNHAIRIKKLPK | 401 | O75534 | |
| KKVRALKGHVEQKRL | 191 | Q13625 | |
| KKPLILKRKHATQGT | 486 | Q8WWL7 | |
| EIKKKKHLFGLRIRV | 336 | Q9Y483 | |
| LSKKLAAIKRKIHPD | 226 | P42696 | |
| VKRKHPRRAQDSKKP | 176 | Q9UGY1 | |
| HKTRLKKILKESRQR | 411 | Q86VS3 | |
| KRHKKRGIFPKVATN | 271 | O00470 | |
| QTKKKGVKRPARLHT | 216 | Q9NZM5 | |
| KVTVKLKPRLRAVHG | 4326 | Q8NEZ4 | |
| KLVRPKRKHGTKSAE | 206 | P42679 | |
| VRVHLSQKYKRIKKP | 466 | P43243 | |
| KTVKPGKVINKDLRH | 101 | Q5TCQ9 | |
| PRRRKSKQHFVEKNK | 246 | Q6NUN7 | |
| IRPLHRKGSLQKKIV | 341 | P46934 | |
| HKKLRSKRVAPVLIR | 251 | P30419 | |
| LLLPVKKTQRRKNTH | 461 | Q6ZWT7 | |
| KHFQLKRKPKSATLR | 161 | Q9H3P2 | |
| VIGKKKKVPRRVIHF | 46 | Q8N128 | |
| AVKKAQLRSAPRAKK | 76 | Q92831 | |
| NLEKRKRKKVLVHLG | 261 | Q09328 | |
| KPLLSKIKLRNHCKR | 446 | Q4FZB7 | |
| KVPKRQSHLKHVARK | 1496 | Q8IYD8 | |
| RKQLIPIRHTKTREK | 341 | Q9HDC5 | |
| LRGLVRPHKKRKKLS | 501 | Q9NY93 | |
| RREKLHKVAPKIKAL | 531 | Q99259 | |
| KHKKDIGPNKRAVRR | 251 | P54652 | |
| PKKSHRQSHRKKVLP | 1686 | Q9Y4D7 | |
| AEIHILKNKGRKRKL | 546 | Q14807 | |
| IVNQLKKIIKRKHTL | 271 | Q8NEN9 | |
| PVRHKEFQRNIKKKR | 61 | A8MQ11 | |
| KNVARLPKSTKKHAI | 66 | Q9P104 | |
| HSEQKKRKLILPKRL | 306 | Q86WC4 | |
| LSALTRKKRKAHVKR | 756 | Q9H8H2 | |
| RKKIHRRVLKKNPLK | 306 | P36578 | |
| AIKTVKHFIEKPRKR | 1921 | A2RRP1 | |
| PLHRKKLVLAVKAIN | 606 | Q8ND30 | |
| HKGKQRKVVDHPKRR | 101 | P61366 | |
| RVKKTKAAAHFLPKL | 186 | Q92914 | |
| VRRGSAKKKIHPLQV | 871 | Q9UI47 | |
| IRGTVKPKRRKKHAV | 121 | Q6UWH4 | |
| KPVKNARISVKGIRH | 516 | Q66K79 | |
| ERHIQLVKKRGKVKA | 51 | O94808 | |
| KNITRLPRETKKHAV | 66 | Q6PKX4 | |
| QKKHRKLSELERPHK | 156 | Q14241 | |
| AAKKAKLRSNPVKVR | 141 | Q5JV73 | |
| AAKHKLAVKPKKQRV | 156 | Q6ZU35 | |
| LAVKPKKQRVSKKHR | 161 | Q6ZU35 | |
| ARHIKKSEGQKIPKV | 56 | Q9UBP9 | |
| PRKAVRVLLNKKTAH | 191 | O43602 | |
| NRKIKKLAESHPKIL | 3936 | Q8WXX0 | |
| RITLKKPSNRHEVKR | 106 | Q9NZ38 | |
| RRAKKIPKINILHKQ | 306 | Q6K0P9 | |
| SHKRTKAPKQARKER | 6 | Q9BQM9 | |
| LSARENKSPKKRHTK | 111 | Q08554 | |
| TIKRIPIHRRAKQAK | 51 | Q5T7N3 | |
| KLEHFTKLRPKRNKK | 981 | Q5VZK9 | |
| ARHRKTGQKVALKKV | 36 | P50750 | |
| KFIKKRVGTHIRAKR | 71 | Q9Y3U8 | |
| RIIKHIAKKNGKSLP | 301 | O15244 | |
| KAKKIKSQHRPTQRF | 361 | Q96KN3 | |
| KVARAHPKAKLVLRI | 141 | P11926 | |
| KRRKVQTHLIKPGTK | 21 | Q9H7T9 | |
| LTRHLTGIIKKRQKK | 326 | Q7Z2Y5 | |
| AQREKRKNKIPKHVK | 541 | Q9BRS2 | |
| PENSLKKRVKEIVHK | 96 | Q9NUJ3 | |
| AKPLTHRRPKVKQKD | 196 | Q96L03 | |
| AILTPKKHTVKKRIG | 181 | P17081 | |
| TPHFNRKRLSKLIKK | 316 | Q14684 | |
| HTTLPQRRRLQKKKA | 561 | Q14684 | |
| PAVKHRKKSLIRLDK | 1461 | Q8WXH0 | |
| HKQTKKRRILIPSDI | 451 | P30414 | |
| HTKKLPRKTHRGLRK | 236 | P39023 | |
| HKRKLFVNTSKRPPK | 96 | Q5VZ19 | |
| KILEKRHIIKENKVP | 111 | O15530 | |
| LPVRHKEFQRNIKKK | 231 | O95744 | |
| RPNPHDTKVKKKLRT | 906 | P28715 | |
| NRLRKDQLKKLPVHK | 216 | O43567 | |
| AHRLKPIRQKTKKAV | 596 | O00444 | |
| AAQPHTVRRTKKLKV | 121 | Q8N5C6 | |
| ESRPLHKKKKRLAKN | 391 | Q86UX6 | |
| AVKPKKKHLHRTIEQ | 211 | Q15003 | |
| KHIKLAKRRIPPASK | 501 | Q5T6F2 | |
| VEGQIHKLRLKLRKK | 881 | Q5W0Q7 | |
| PKTIKQRHVRKKRKI | 271 | Q96LT9 | |
| HPLRRLKKANDKKRT | 1401 | Q76I76 | |
| RVVLKTPAKRHKQLK | 1096 | O94759 | |
| KKDRPRKHLTLNNKV | 551 | P23497 | |
| APHKTVSQKKRKIAV | 476 | Q5VUG0 | |
| IPLSIKNLKRKHKRK | 516 | Q9C0C9 | |
| KNNKKVRVTVKPHLL | 1071 | Q8IZH2 | |
| SPNQLKRKILIKHKK | 451 | P19174 | |
| LAKRAKAVVQLKPRH | 921 | Q15149 | |
| LPDRKKKFQTRVHRK | 276 | Q6XYQ8 | |
| QKKIPIKRADILKHV | 101 | Q96MG7 | |
| KHVSLNKAKKRRLPR | 1141 | P78527 | |
| KIHKRPHRIQKARKS | 676 | Q9H582 | |
| KCSAVKHNRIKGIPK | 426 | P11388 | |
| ERTKHRRKQKTPKKF | 416 | Q96KM6 | |
| LIRSPRHEKKKKVRK | 76 | P26368 | |
| SHRRIKKLKTEKVDP | 291 | Q9ULD9 | |
| RPRLKPQTKKAKLHQ | 356 | Q9UDV6 | |
| VKKQPKIRHRILRHT | 1056 | Q9Y2L5 | |
| QHKKQRVKLPSKALV | 286 | Q9NRL3 | |
| KPLFVRHRTQKEIKQ | 181 | P0C7P4 | |
| RETVKNKSTHLKKPL | 36 | Q70YC4 | |
| LDPTNHKRKKRQSIK | 411 | Q9Y6X0 | |
| KRKHKKKRLVQSPNS | 16 | P42677 | |
| VSKEKRKRSPKHRSK | 1886 | P18583 | |
| KKIHIRQKPCIVKNV | 416 | Q5JVG8 | |
| PKDTRHQRKNKSKAI | 651 | Q6NUM6 | |
| SPKRKKQHKKYRSVI | 461 | Q8TEY7 | |
| CISRKKLEHRIKQPT | 111 | Q92563 | |
| KRIRPRACKNHKSKL | 171 | Q86TC9 |